Morgan Stanley’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,931
| Closed | -$5.57K | – | 7985 |
|
|
2022
Q4 | $5.57K | Sell |
13,931
-2,400
| -15% | -$960 | ﹤0.01% | 7119 |
|
|
2022
Q3 | $16K | Buy |
16,331
+15,971
| +4,436% | +$15.6K | ﹤0.01% | 6906 |
|
|
2022
Q2 | $0 | Sell |
360
-1,717
| -83% | – | ﹤0.01% | 8156 |
|
|
2022
Q1 | $8K | Buy |
2,077
+380
| +22% | +$1.46K | ﹤0.01% | 7483 |
|
|
2021
Q4 | $14K | Buy |
1,697
+1,337
| +371% | +$11K | ﹤0.01% | 7360 |
|
|
2021
Q3 | $4K | Hold |
360
| – | – | ﹤0.01% | 7569 |
|
|
2021
Q2 | $4K | Sell |
360
-3,813
| -91% | -$42.4K | ﹤0.01% | 7463 |
|
|
2021
Q1 | $46K | Buy |
+4,173
| New | +$46K | ﹤0.01% | 6388 |
|